Page 2 - Merck Sharp Dohme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Syncona : Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study

Syncona : Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJulia wilsonEduard gasalMerck sharp dohmeMerck co incJw communicationsInvestigational new drugChief medical officerMerck sharp

TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024

TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiAkseli hemminkiAino kalervoDaniel goochMerck co incMerck kgaAmerican society of clinical oncologyUs department of defenseUniversity of helsinkiMerck sharp dohmeHealth affairsMerck kgaaEuropean innovation councilDepartment of defenseScius communications

TME Pharma N V : TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders

Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment

United statesFrance generalNoord hollandMerck keytrudaArthur rouillGuillaume van renterghemLee schalopPharmanv euronextAram mangasarianMerck sharp dohme corpCollege of artsUniversity wharton schoolVagelos program in life sciencesAlbert einstein college of medicineMorgan stanleyArticles of association

Evaxion Biotech A/S to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

Evaxion Biotech A/S announced its participation in the American Society of Clinical Oncology Annual Meeting, where it will present positive immune data form its ongoing EVX-01 Phase 2 study. The.

United statesMerck sharp dohmeAmerican society of clinical oncologyEvaxion biotechAmerican societyClinical oncologyAnnual meetingMerck sharp

Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

TOKYO, May 23, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society

United statesAmerican society of clinical oncologyEisai co ltdBliss biopharmaceutical hangzhou co ltdMerck co incMerck sharp dohmeBiolab co ltdPublic relations departmentClinical oncologyAnnual meetingNew windowTakashi owaChief scientific officerSenior vice presidentBliss biopharmaceuticalZhejiang province